Health and Fitness Health and Fitness
Mon, October 29, 2012
[ Mon, Oct 29th 2012 ] - Market Wire
MSA Engineer Named Rising Star of Safety by the National Safety Council
[ Mon, Oct 29th 2012 ] - Market Wire
Jazz Pharmaceuticals Announces Date to Release Third Quarter 2012 Results
[ Mon, Oct 29th 2012 ] - Market Wire
BIOLASE to Discuss Third Quarter 2012 Financial Results on November 5, 2012 Conference Call
[ Mon, Oct 29th 2012 ] - Market Wire
Analyst Opinion on Eli Lilly &;; Co. an .. turers Countering Patent Expirations with New Pro
[ Mon, Oct 29th 2012 ] - Market Wire
Financial Review on Healthcare Stocks DaVita Inc. .. pecialized Health Industry Faces Growth Obstacles
[ Mon, Oct 29th 2012 ] - Market Wire
Watson Announces Sale of Rugby OTC Product Tradem .. aceuticals, a division of The Harvard Drug Group,
[ Mon, Oct 29th 2012 ] - Market Wire
Trimel Pharmaceuticals Corporation to Report Thir .. ts and Host a Conference Call to Update Investors
[ Mon, Oct 29th 2012 ] - Market Wire
IsoRay's Brain and Lung Cancer Products Showcased .. Society for Radiation Oncology (ASTRO) Convention
[ Mon, Oct 29th 2012 ] - Market Wire
NuVasive Announces Outstanding Showing at NASS 2012
[ Mon, Oct 29th 2012 ] - Market Wire
Cynapsus Therapeutics' APL 130277 for Parkinson's .. The Top Ten Neurology Projects To Watch For 2012
[ Mon, Oct 29th 2012 ] - Market Wire
ProPhase Labs Rejects Non-Binding Revised Proposa .. xx Initiatives to Be Acquired for $1.60 per Share
[ Mon, Oct 29th 2012 ] - Market Wire
Horizon Pharma to Host an Investment Community Briefing on RAYOS(R) on Monday, November 12, 2012
[ Mon, Oct 29th 2012 ] - Market Wire
Theratechnologies to Host Conference Call
[ Mon, Oct 29th 2012 ] - Market Wire
Bioheart to Initiate ANGEL Trial in Mexico
[ Mon, Oct 29th 2012 ] - Market Wire
Former Under Secretary of Homeland Security Asa H .. Having a Personal Health Record for Emergency Pre
[ Mon, Oct 29th 2012 ] - Market Wire
Stem Cell Therapeutics Announces Admission to Cen .. zation of Regenerative Medicine (CCRM) Consortium
[ Mon, Oct 29th 2012 ] - Market Wire
BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies
Sun, October 28, 2012
[ Sun, Oct 28th 2012 ] - Market Wire
Varian Medical Systems Unveils EDGEa" Radiosurger .. ive Solution for Non-Invasive Surgical Procedures
[ Sun, Oct 28th 2012 ] - Market Wire
Accuray Launches New TomoTherapy Ha" Series Featuring TomoEDGEa"
Fri, October 26, 2012
[ Fri, Oct 26th 2012 ] - Market Wire
Watson Receives FDA Approval for Generic Actos
[ Fri, Oct 26th 2012 ] - Market Wire
NuVasive Announces PMA Approval of the PCM(R) Cervical Disc System
[ Fri, Oct 26th 2012 ] - Market Wire
Abbott Announces Cash Tender Offers for Notes
[ Fri, Oct 26th 2012 ] - Market Wire
Accelerated Growth in Terms of Sales and Profitability at Ergoresearch Ltd
[ Fri, Oct 26th 2012 ] - Market Wire
Identifying Opportunity, Placing Risk - Consensus .. gen Idec Inc. and Regeneron Pharmaceuticals, Inc.
[ Fri, Oct 26th 2012 ] - Market Wire
Timing Is Crucial, Upside Analysis - New Outlook on Aetna Inc. and Cigna Corporation
[ Fri, Oct 26th 2012 ] - Market Wire
Factors of Influence, Economy and Policy -- Resea .. Celgene Corporation and Teva Pharmaceutical Indu
[ Fri, Oct 26th 2012 ] - Market Wire
Substantial Clinical Evidence and Adoption Presen .. ay's TomoTherapy Asia Pacific Users' Meeting 2012
[ Fri, Oct 26th 2012 ] - Market Wire
Watson Confirms FDA Denies Appeal Related to Prochieve NDA for the Prevention of Preterm Birth
[ Fri, Oct 26th 2012 ] - Market Wire
CareFusion To Report Preliminary Fiscal 2013 First Quarter Results On Nov. 8
[ Fri, Oct 26th 2012 ] - Market Wire
Cambrex to Announce Third Quarter 2012 Financial Results on October 31, 2012

Cambrex to Announce Third Quarter 2012 Financial Results on October 31, 2012


Published on 2012-10-26 05:18:38 - Market Wire
  Print publication without navigation


Cambrex to Announce Third Quarter 2012 Financial Results on October 31,... -- EAST RUTHERFORD, N.J., Oct. 26, 2012 /PRNewswire/ --

EAST RUTHERFORD, N.J., Oct. 26, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: [ CBM ]) announced that third quarter 2012 financial results will be released on Wednesday, October 31, 2012 after the market closes.

The Company will host a conference call to discuss the financial results.

   Third Quarter 2012 Earnings Conference Call


When:  

Thursday, November 1, 2012 at 8:30 a.m. Eastern Time



Dial-in:  

1-888-430-8705 for U.S.


1-719-325-2455 for International


Passcode:  1704787



Dial-in Replay:

1-888-203-1112 for U.S.


1-719-457-0820 for International


Passcode: 1704787


Available through Thursday, November 8, 2012



Webcast:

[ www.cambrex.com ]   

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit [ www.cambrex.com ].  

SOURCE Cambrex Corporation



RELATED LINKS
[ http://www.cambrex.com ]
Contributing Sources